Patents Assigned to Mitsubishi Pharma Corp.
  • Use of substituted 8-Perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-] pyrimidin-4-one derivatives as therapeutic agents
    Patent number: 7393853
    Abstract: The invention relates to use of a substituted-pyrimidone derivative represented by formula (I) or a salt thereof: wherein X, Y, R1, R2, R3, R4, R5, n, p and q are as described herein for treating a variety of disease states. More specifically, the invention relates to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of GSK3?, such as Pick's disease.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: July 1, 2008
    Assignees: Sanofi Aventis, Mitsubishi Pharma Corp.
    Inventors: Alistair Lochead, Mourad Saady, Franck Slowinski, Philippe Yaiche
  • Production of 2-amin-2-[2-(2-(40-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols
    Patent number: 6605744
    Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: August 12, 2003
    Assignees: Novartis AG, Taito Co. Ltd., Mitsubishi Pharma Corp.
    Inventors: Stephan Abel, Tetsuro Fujita, Ryoji Hirose, Guido Jordine, Tadashi Mishina